Enovis ROA 2012-2026 | ENOV
Current and historical return on assets (ROA) values for Enovis (ENOV) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Enovis ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2026-03-31 | $-1.14B | $4.28B | -26.59% |
| 2025-12-31 | $-1.19B | $4.54B | -26.10% |
| 2025-09-30 | $-1.37B | $4.76B | -28.71% |
| 2025-06-30 | $-0.83B | $5.04B | -16.42% |
| 2025-03-31 | $-0.81B | $5.15B | -15.74% |
| 2024-12-31 | $-0.83B | $5.30B | -15.59% |
| 2024-09-30 | $-0.12B | $5.25B | -2.29% |
| 2024-06-30 | $-0.09B | $4.96B | -1.84% |
| 2024-03-31 | $-0.08B | $4.71B | -1.74% |
| 2023-12-31 | $-0.03B | $4.41B | -0.75% |
| 2023-09-30 | $-0.08B | $4.36B | -1.72% |
| 2023-06-30 | $-0.14B | $4.37B | -3.18% |
| 2023-03-31 | $-0.05B | $4.38B | -1.19% |
| 2022-12-31 | $-0.01B | $5.43B | -0.26% |
| 2022-09-30 | $0.02B | $6.49B | 0.35% |
| 2022-06-30 | $0.12B | $7.37B | 1.57% |
| 2022-03-31 | $0.07B | $8.13B | 0.84% |
| 2021-12-31 | $0.07B | $8.03B | 0.90% |
| 2021-09-30 | $0.11B | $7.74B | 1.38% |
| 2021-06-30 | $0.09B | $7.53B | 1.25% |
| 2021-03-31 | $0.06B | $7.42B | 0.77% |
| 2020-12-31 | $0.04B | $7.27B | 0.58% |
| 2020-09-30 | $-0.01B | $7.28B | -0.11% |
| 2020-06-30 | $-0.01B | $7.89B | -0.14% |
| 2020-03-31 | $-0.47B | $8.58B | -5.50% |
| 2019-12-31 | $-0.53B | $9.35B | -5.65% |
| 2019-09-30 | $-0.47B | $9.15B | -5.08% |
| 2019-06-30 | $-0.44B | $8.37B | -5.31% |
| 2019-03-31 | $0.06B | $7.51B | 0.84% |
| 2018-12-31 | $0.14B | $6.60B | 2.12% |
| 2018-09-30 | $0.11B | $6.63B | 1.62% |
| 2018-06-30 | $0.12B | $6.72B | 1.81% |
| 2018-03-31 | $0.14B | $6.79B | 2.02% |
| 2017-12-31 | $0.15B | $6.68B | 2.26% |
| 2017-09-30 | $0.18B | $6.58B | 2.67% |
| 2017-06-30 | $0.16B | $6.51B | 2.43% |
| 2017-03-31 | $0.15B | $6.47B | 2.24% |
| 2016-12-31 | $0.13B | $6.55B | 1.97% |
| 2016-09-30 | $0.14B | $6.64B | 2.03% |
| 2016-06-30 | $0.13B | $6.77B | 1.85% |
| 2016-03-31 | $0.14B | $6.88B | 2.01% |
| 2015-12-31 | $0.17B | $6.93B | 2.41% |
| 2015-09-30 | $0.20B | $7.05B | 2.88% |
| 2015-06-30 | $0.26B | $7.17B | 3.60% |
| 2015-03-31 | $0.40B | $7.40B | 5.36% |
| 2014-12-31 | $0.37B | $7.36B | 5.03% |
| 2014-09-30 | $0.33B | $7.21B | 4.51% |
| 2014-06-30 | $0.30B | $6.91B | 4.37% |
| 2014-03-31 | $0.16B | $6.45B | 2.53% |
| 2013-12-31 | $0.16B | $6.22B | 2.54% |
| 2013-09-30 | $0.14B | $6.11B | 2.26% |
| 2013-06-30 | $0.09B | $6.04B | 1.52% |
| 2013-03-31 | $0.05B | $6.01B | 0.76% |
| 2012-12-31 | $-0.08B | $6.09B | -1.36% |
| 2012-09-30 | $-0.11B | $4.82B | -2.37% |
| 2012-06-30 | $-0.11B | $3.57B | -3.20% |
| 2012-03-31 | $-0.11B | $2.33B | -4.76% |
| 2011-12-31 | $0.01B | $1.06B | 0.47% |
| 2011-09-30 | $0.03B | $1.05B | 2.87% |
| 2011-06-30 | $0.03B | $1.04B | 3.08% |
| 2011-03-31 | $0.02B | $1.01B | 2.37% |
| 2010-12-31 | $0.02B | $1.00B | 1.71% |
| 2010-09-30 | $0.02B | $0.99B | 1.51% |
| 2010-06-30 | $0.02B | $1.00B | 1.51% |
| 2010-03-31 | $0.02B | $0.98B | 1.73% |
| 2009-12-31 | $0.02B | $0.96B | 2.51% |
| 2009-09-30 | $0.03B | $0.93B | 3.01% |
| 2009-06-30 | $0.04B | $0.91B | 3.95% |
| 2009-03-31 | $0.00B | $0.92B | -0.33% |
| 2008-12-31 | $0.00B | $0.93B | -0.32% |
| 2008-09-30 | $-0.01B | $0.92B | -1.19% |
| 2008-06-30 | $0.00B | $0.69B | 0.00% |
| 2008-03-31 | $0.04B | $0.45B | 8.83% |
| 2007-12-31 | $0.04B | $0.22B | 17.39% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.405B | $2.248B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |